1[1]Apsimon HT,Reef H,Phadke RV,et al.A population-based study of brain arteriovenous malformation:long-term treatment outcomes[J].Stroke,2002,33:2794-2800.
2[2]Stefani MA,Porter PJ,Terbrugge KG,et al.Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation[J].Stroke,2002,33:920-924.
3[3]Todaka T,Hamada JI,Kai Y,et al.Analysis of mean transit time of contrast medium in ruptured and unruptured arteriovenous malformations[J].Stroke,2003,34:2410-2414.
4[4]Connors JJ,Wojak JC.Intracranial arteriovenous malformations general considerations[J].Interven Neuroradiol,1999,25:227-240.
5[5]Raupp EF,Fernandes J.Does treatment with N-butyl cyanoacrylate embolization protect against hemorrhage in cerebral arteriovenous malformations?[J].Arq Neuropsiquiatr,2005,63:34-39.
6[6]Hartmann A,pile-Spellman J,Stapf C,et al.Risk of endovascular teatment of brain arteriovenous malformations[J].Stroke,2002,33:1816-1820.
7[7]Hartmann A,Stapf C,Hofmeister C,et al.Determinants of neurological outcome after surgery for brain arteriovenous malformation[J].Stroke,2000,31:2361-2364.
8[8]Hartmann A,Mast H,Sciacca RR,et al.Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations[J].Stroke,2005,36:2431-2435.
9[9]Yu SC,Chan MS,Lam JM,et al.Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylaye embolization:Initial success and rate of permanent cure[J].AJNR AM J Neuroradiol,2004,25:1139-1143.
1D. R. Warakaulle,R. I. Aviv,D. Niemann,A. J. Molyneux,J. V. Byrne,P. Teddy.Embolisation of spinal dural arteriovenous fistulae with Onyx[J].Neuroradiology.2003(2)
2Molyneux AJ,Cekirge S,Saatci I,et al.Cerebral aneurysm multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20European centers[].American Journal of Neuroradiology.2004
3Duffner F,Ritz R,Bornemann A,et al.Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate ( NBCA)[].Clinical Neuropathology.2002
4Hamada J,Kai Y,Morioka M,et al.A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study[].Journal of Neurosurgery.2002
5Hamada J,Kai Y,Morioka M,et al.A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience[].Journal of Neurosurgery.2002
6Jahan R,Murayama Y,GobinYP,et al.Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients[].Neurosurgery.2001
7Florio F,Lauriola W,Nardella M,et al.Endovascular treatment of intracranial arterio-venous malformations with Onyx embolization: preliminary experience[].Radiologia Medica.2003
8Murayama Y,Vinuela F,Tateshima S,et al.Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices[].American Journal of Neuroradiology.2000
